US Stock MarketDetailed Quotes
KRRO Korro Bio
- 65.730
- +5.600+9.31%
Close Nov 5 16:00 ET
611.21MMarket Cap-6491P/E (TTM)
66.010High60.080Low61.22KVolume61.110Open60.130Pre Close3.89MTurnover1.38%Turnover RatioLossP/E (Static)9.30MShares98.00052wk High3.09P/B291.58MFloat Cap30.00552wk Low--Dividend TTM4.44MShs Float2918.500Historical High--Div YieldTTM9.86%Amplitude9.150Historical Low63.626Avg Price1Lot Size
Korro Bio Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||||
| Gross profit | |||||||
| Operating expense | 31.06%24.13M | 6.81%21.45M | 43.28%84.53M | 18.41M | 20.09M | 66.22%59M | 35.49M |
| Selling and administrative expenses | 32.30%6.99M | 46.16%7.88M | 62.43%27.28M | --5.28M | --5.39M | 43.70%16.8M | --11.69M |
| -General and administrative expense | 32.30%6.99M | 46.16%7.88M | 62.43%27.28M | --5.28M | --5.39M | 43.70%16.8M | --11.69M |
| Research and development costs | 30.56%17.14M | -7.64%13.57M | 35.66%57.25M | --13.13M | --14.69M | 77.28%42.2M | --23.81M |
| Operating profit | -31.06%-24.13M | -6.81%-21.45M | -43.28%-84.53M | -18.41M | -20.09M | -66.22%-59M | -35.49M |
| Net non-operating interest income expense | |||||||
| Other net income (expense) | 196.31%2.33M | 297.71%1.91M | 247.23%3.39M | 786K | 481K | -92.79%976K | 13.54M |
| Other non- operating income (expenses) | 196.31%2.33M | 297.71%1.91M | 247.23%3.39M | --786K | --481K | -92.79%976K | --13.54M |
| Income before tax | -23.69%-21.8M | 0.33%-19.54M | -39.85%-81.15M | -17.62M | -19.61M | -164.25%-58.02M | -21.96M |
| Income tax | 11.11%30K | 17K | 170.00%27K | 27K | 0 | 400.00%10K | 2K |
| Net income | -23.67%-21.83M | 0.24%-19.56M | -39.87%-81.17M | -17.65M | -19.61M | -164.27%-58.03M | -21.96M |
| Net income continuous Operations | -23.67%-21.83M | 0.24%-19.56M | -39.87%-81.17M | ---17.65M | ---19.61M | -164.27%-58.03M | ---21.96M |
| Minority interest income | |||||||
| Net income attributable to the parent company | -23.67%-21.83M | 0.24%-19.56M | -39.87%-81.17M | -17.65M | -19.61M | -164.27%-58.03M | -21.96M |
| Preferred stock dividends | |||||||
| Other preferred stock dividends | |||||||
| Net income attributable to common stockholders | -23.67%-21.83M | 0.24%-19.56M | -39.87%-81.17M | -17.65M | -19.61M | -164.27%-58.03M | -21.96M |
| Basic earnings per share | -10.17%-2.43 | 0.42%-2.44 | -631.85%-53.08 | -2.2058 | -2.4502 | -164.27%-7.2528 | -2.7444 |
| Diluted earnings per share | -10.17%-2.43 | 0.42%-2.44 | -631.85%-53.08 | -2.2058 | -2.4502 | -164.27%-7.2528 | -2.7444 |
| Dividend per share | |||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data